IP Library Granted Patent US 10,653,635
Granted Patent B2
US 10,653,635 · App. 15/857,737 · Granted May 19, 2020

Nanofiber scaffolds for biological structures

Inventor: Jed K. Johnson (London, OH)
Assignee: NANOFIBER SOLUTIONS, LLC
A61K9/70A61K35/12A61K47/32A61L27/3804A61L27/54A61L27/60A61L2300/252A61L2300/406A61L2300/41A61L2300/414
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,653,635
App. No.
15/857,737
Granted
May 19, 2020
Kind
B2
Abstract

A system for manufacturing an artificial construct suitable for transplantation into a biological organism that includes a two or three three-dimensional preform that is based on the actual two or three-dimensional structure of a native mammalian tissue; and an electrospinning apparatus, wherein the electrospinning apparatus is operative to deposit at least one layer of polymer fibers on the preform to form a polymer scaffold, and wherein the orientation of the fibers in the scaffold relative to one another is substantially parallel.

Claims (16)

1. A synthetic construct comprising:

at least one layer of electrospun polymer fibers, wherein at least about 75% of the fibers have a fiber angle within about 10° of parallel.

2. The synthetic construct of claim 1 , having a shape of a patch and a thickness from about 0.2 mm to about 3 mm.

3. The synthetic construct of claim 1 , further comprising a type of biological cell selected from the group consisting of cord blood cells, embryonic stem cells, induced pluripotent cells, mesenchymal cells, placental cells, bone marrow derived cells, hematopoietic cell, epithelial cells, endothelial cells, fibroblasts and chondrocytes.

4. The synthetic construct of claim 1 , further comprising a compound selected from the group consisting of proteins, peptides, cytokines, growth factors, antibiotic compounds, anti-inflammatory compounds, and combinations thereof.

5. The synthetic construct of claim 1 , wherein the electrospun polymer fibers comprise a polymer selected from the group consisting of polyethylene terephthalate, silicone, polyurethane, polycarbonate, polyether ketone, polycaprolactone, polylactic acid, polyglycolic acid, collagen, gelatin, fibronectin, hyaluronic acid, and combinations thereof.

6. The synthetic construct of claim 1 , wherein about 92% of the fibers have a fiber angle within about 10° of parallel.

7. The synthetic construct of claim 1 , wherein about 98% of the fibers have a fiber angle within about 10° of parallel.

8. A method comprising:

applying to a wound a synthetic construct comprising at least one layer of electrospun polymer fibers, wherein at least about 75% of the fibers have a fiber angle within about 10° of parallel.

9. The method of claim 8 , wherein the synthetic construct has a shape of a patch and a thickness from about 0.2 mm to about 3 mm.

10. The method of claim 8 , wherein the synthetic construct further comprises a type of biological cell selected from the group consisting of cord blood cells, embryonic stem cells, induced pluripotent cells, mesenchymal cells, placental cells, bone marrow derived cells, hematopoietic cell, epithelial cells, endothelial cells, fibroblasts and chondrocytes.

11. The method of claim 8 , wherein the synthetic construct further comprises a compound selected from the group consisting of proteins, peptides, cytokines, growth factors, antibiotic compounds, anti-inflammatory compounds, and combinations thereof.

12. The method of claim 8 , wherein the electrospun polymer fibers comprise a polymer selected from the group consisting of polyethylene terephthalate, silicone, polyurethane, polycarbonate, polyether ketone, polycaprolactone, polylactic acid, polyglycolic acid, collagen, gelatin, fibronectin, hyaluronic acid, and combinations thereof.

13. The method of claim 8 , wherein about 92% of the fibers have a fiber angle within about 10° of parallel.

14. The method of claim 8 , wherein about 98% of the fibers have a fiber angle within about 10° of parallel.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 4, 2022
From: NANOFIBER SOLUTIONS, LLC
To: NFS IP HOLDINGS, LLC
Reel/Frame 061882/0663 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 22, 2020
From: JOHNSON, JED K.
To: NANOFIBER SOLUTIONS, LLC
Reel/Frame 052458/0796 →
CHANGE OF NAME Recorded Mar 21, 2019
From: NANOFIBER SOLUTIONS, INC.
To: NANOFIBER SOLUTIONS, LLC
Reel/Frame 048680/0973 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 5, 2018
From: JOHNSON, JED K.
To: NANOFIBER SOLUTIONS, INC.
Reel/Frame 045993/0097 →
Continuity (3)
Continuation 13740913 · Jan 14, 2013
Provisional Application 61585869 · Jan 12, 2012
Related Publication 20180116973A1 · May 3, 2018